1

Mini-antibodies Reactivate tumor suppressor p53: A Promising Pathway for Tumor Management

News Discuss 
A major advance in cancer investigation is occurring with the use of nanobodies to re-engage damaged p53. This vital malignant suppressor protein is frequently inactivated in various types of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story